No recent news briefings were available in the provided context for Danaher Corporation as of the generation date of 11 September 2026. This report is therefore based on verified financial filings and ownership data disclosed in regulatory submissions.
Danaher's trailing twelve-month revenue stood at $25.1 billion, reflecting year-over-year growth of 5.5%, while net income for the same period was $4.0 billion, yielding a net margin of 15.9% [SEC 10-Q - DHR - 2026-06-26]. Gross margin was recorded at 58.5% and operating margin at 20.4%, with earnings per share growing 59.7% year-over-year. The company held $4.3 billion in cash against total debt of $27.97 billion. The price-to-earnings ratio stood at 35.55, with a market capitalisation of approximately $140.95 billion at the time of the filing reference date [SEC 10-Q - DHR - 2026-06-26].
Insider activity has been the primary trigger for this report. Over the past 30 days, three insider transactions were recorded, all in the direction of selling, with a combined net disposal value of approximately $12.74 million [SEC Form 4 - DHR - 2026-09]. No institutional 13F filing data was included in the provided context for this reporting period, so holdings changes among notable asset managers cannot be cited here.
The prevailing macro environment reflects a normal yield curve, with the 10-year US Treasury yield at 4.83% and the 2-year yield at 4.39% [FRED DGS10; FRED DGS2]. The spread of 44 basis points between the two tenors indicates a positively sloped curve, a condition that has historical relevance for capital-intensive industrial and life sciences companies carrying long-duration debt obligations such as those reflected on Danaher's balance sheet.